Role of high dose octreotide LAR for the treatment of GEP-NETs

Neuroendocrine Tumours (NETs) are a heterogeneous group of rare neoplasms that account for 0,5% of all malignancies. The increased incidence observed in the last few decades may be accounted for by increased awareness, improved diagnostic tools and a revision in the definition. The main primary site...

Descripció completa

Dades bibliogràfiques

Autors principals:	Giulia M. Franchi, Chiara Cappelletti, Valentina V. Villa, Emanuele Bosi, Marco F. Manzoni
Format:	Artigo
Idioma:	Inglês
Publicat:	SEEd 2009-03-01
Col·lecció:	Clinical Management Issues
Matèries:	Gastro-entero-pancreatic neuroendocrine tumours Somatostatin analogues High dose octreotide LAR Medical treatment Clinical management
Accés en línia:	https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/555
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!